PBMs are Clear as Mud: The Value of a Fee-Based, Transparent Model
Transparency in the drug supply chain is desperately needed to deliver consumers the lowest cost and highest value prescription drugs.
Transparency in the drug supply chain is desperately needed to deliver consumers the lowest cost and highest value prescription drugs.
February 26, 2025 The Alliance of Community Health Plans (ACHP) sent a letter to the Energy and Commerce Subcommittee on Health with comments on pharmacy benefit manager (PBM) transparency, encouraging comprehensive reform to bring much-needed relief to patients at the pharmacy counter. The letter was sent ahead of the hearing An Examination of How Reining in PBMs Will … Continued
As the only national payer group to push for comprehensive drug reforms, ACHP believes that it is past time for pharmaceutical companies to answer for their pricing practices.
ACHP sent a letter to the Trump HHS Transition Team outlining policy priorities for community health plans in 2025
ACHP recently sent a letter to Congress expressing the health care priorities we hope to see before the legislative session concludes.